Triazine derivative, chymase activity inhibitor and nitric oxide production inhibitor
申请人:Wakamoto Pharmaceutical Co., Ltd.
公开号:EP0713876A1
公开(公告)日:1996-05-29
The present invention provides novel triazine derivatives which inhibit chymase activity and nitric oxide production. The triazine derivatives are useful for the prevention and treatment of bronchial asthma, allergic rhinitis and hives by inhibiting chymase activity, and are useful for the prevention and treatment of cardiopathy and cerebrovascular disease, ishemic heart disease, septic shock, ache, rheumatic fever, arthritis, asthma, immunodeficiency, viral or non-viral infections, autoimmune diseases and cancer by inhibiting nitric oxide production.
本发明提供了新颖的三嗪衍生物,可以抑制钳形酶活性和一氧化氮产生。这些三嗪衍生物通过抑制钳形酶活性对预防和治疗支气管哮喘、过敏性鼻炎和荨麻疹具有用处,并且通过抑制一氧化氮产生对预防和治疗心脏病和脑血管疾病、缺血性心脏病、感染性休克、疼痛、风湿热、关节炎、哮喘、免疫功能缺陷、病毒或非病毒感染、自身免疫疾病和癌症具有用处。